The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension - Concepedia

Concepedia

Publication | Open Access

The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension

DOI Full Paper Access

249

Citations

15

References

2013

Year

Henry G. Bone, Roland Chapurlat, Maria Luisa Brandi, Jacques P. Brown, E. J. Czerwiński, Marc-Antoine Krieg, Dan Mellström, S. Radominski, Jean‐Yves Reginster, Heinrich Resch,

The Journal of Clinical Endocrinology & Metabolism

Abstract

Denosumab treatment for 6 years remained well tolerated, maintained reduced bone turnover, and continued to increase BMD. Fracture incidence remained low.

References

	Year	Citations

Page 1